Pages that link to "Q44781213"

The following pages link to Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models (Q44781213):

Displaying 39 items.

• Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential (Q27748804) (← links)
• Development of a high-throughput cell-based reporter assay to identify stabilizers of tumor suppressor Pdcd4. (Q30878777) (← links)
• Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo (Q33720256) (← links)
• A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas (Q33786955) (← links)
• DNA sequence recognition by the indolocarbazole antitumor antibiotic AT2433-B1 and its diastereoisomer (Q33827012) (← links)
• Protein kinase C targeting in antineoplastic treatment strategies (Q33832628) (← links)
• EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy (Q36103054) (← links)
• Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells (Q36134814) (← links)
• Identification of Ras farnesyltransferase inhibitors by microbial screening (Q36165226) (← links)
• Expression of thymidylate synthase in human cells is an early G(1) event regulated by CDK4 and p16INK4A but not E2F. (Q36611467) (← links)
• Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines (Q36623957) (← links)
• Co-regulative effects of the cAMP/PKA and DAG/PKC signal pathways on human gastric cancer cells during differentiation induced by traditional Chinese medicines (Q36700165) (← links)
• Emerging drug treatments for solid tumours (Q36811466) (← links)
• High-efficiency liposomal encapsulation of a tyrosine kinase inhibitor leads to improved in vivo toxicity and tumor response profile (Q37255085) (← links)
• Role of oxygen radicals generated by NADPH oxidase in apoptosis induced in human leukemia cells (Q37388109) (← links)
• Radiotherapy in conjunction with 7-hydroxystaurosporine: a multimodal approach with tumor pO2 as a potential marker of therapeutic response (Q37445556) (← links)
• A Simple and Improved Active Loading Method to Efficiently Encapsulate Staurosporine into Lipid-Based Nanoparticles for Enhanced Therapy of Multidrug Resistant Cancer. (Q38804342) (← links)
• Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease (Q39387270) (← links)
• Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells (Q40027086) (← links)
• Signal transduction pathways: new targets in oncology (Q40809687) (← links)
• Protein kinase C inhibition by UCN-01 induces apoptosis in human glioma cells in a time-dependent fashion (Q40815555) (← links)
• Cell-signaling targets for antitumour drug development (Q40852621) (← links)
• Therapeutic potential of protein kinase C inhibitors (Q40900661) (← links)
• G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation (Q40901491) (← links)
• The effect of UCN-01 (7-hydroxystaurosporine), a potent inhibitor of protein kinase C, on fractionated radiotherapy or daily chemotherapy of a murine fibrosarcoma (Q41077781) (← links)
• Stimulatory effect of reconstituted basement membrane components (matrigel) on the colony formation of a panel of human lung cancer cell lines in soft agar (Q41138872) (← links)
• Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation (Q41354263) (← links)
• Towards selective pharmacological modulation of protein kinase C--opportunities for the development of novel antineoplastic agents (Q42371610) (← links)
• Tryptophan residues play an important role in the extraordinarily high affinity binding interaction of UCN-01 to human alpha-1-acid glycoprotein (Q45117943) (← links)
• Physiological modeling of altered pharmacokinetics of a novel anticancer drug, UCN-01 (7-hydroxystaurosporine), caused by slow dissociation of UCN-01 from human alpha1-acid glycoprotein. (Q52076650) (← links)
• Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. (Q53234212) (← links)
• Antitumor effect of KT6124, a novel derivative of protein kinase inhibitor K-252a, and its mechanism of action (Q68059378) (← links)
• Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C (Q70733013) (← links)
• Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells (Q71605859) (← links)
• [Growth and invasion of differentiated thyroid gland carcinoma: importance of signal transduction] (Q72262976) (← links)
• Disposition in mice of 7-hydroxystaurosporine, a protein kinase inhibitor with antitumor activity (Q72875651) (← links)
• Cellular relocalisation of protein kinase C-θ caused by staurosporine and some of its analogues (Q73595576) (← links)
• UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines (Q73905120) (← links)
• Development and Characterization of the Solvent-Assisted Active Loading Technology (SALT) for Liposomal Loading of Poorly Water-Soluble Compounds (Q90040561) (← links)